Considering that the level of nuclear ACAT1 is higher in peritumoral tissues than in CRC tumor tissues, we hypothesized that a benign immune microenvironment might facilitate ACAT1 nuclear localization. The gene discussed is ACAT1; the disease is neoplasm.